
Best practice methods for the tech transfer of CGTs can increase process and analytics robustness while remaining scalable.
Matthew Hewitt is vice-president, technical officer, Cell & Gene Therapy & Biologics, at Charles River Laboratories.

December 6th 2023

November 2nd 2023